Rethinking Tuberculosis Treatment: Integrating Antimicrobial Compounds, Host Responses, and Comorbidities
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 7
Special Issue Editors
Interests: infection biology; antibiotic resistance; tuberculosis; bacterial infections; drug development; transcriptomics; enzymes
Special Issues, Collections and Topics in MDPI journals
Interests: immunology and immunotherapy; vaccine; Mycobacterium tuberculosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Tuberculosis (TB) continues to pose a major global health challenge, underscored by the limited efficacy of current therapeutic regimens, the rapid emergence of drug-resistant Mycobacterium tuberculosis strains, and heterogeneous treatment outcomes across patient populations. The failure to effectively integrate antimicrobial drug discovery with host immune modulation, vaccine development, and disease-associated comorbidities has contributed to persistent gaps in TB control.
This Special Issue of Antibiotics focuses on recent advances in anti-tubercular antimicrobial compounds, resistance mechanisms, and therapeutic strategies that extend beyond conventional pathogen-centered approaches. Emphasis is placed on the development of novel drugs, optimization of existing antibiotics, and host-directed therapies that enhance treatment efficacy and shorten disease duration. In parallel, contributions addressing vaccine strategies, drug–vaccine interfaces, and the influence of TB-associated comorbidities such as diabetes and HIV are welcomed. By integrating mechanistic insights with translational perspectives, this Special Issue aims to highlight innovative and realistic therapeutic pathways for improved TB management in the era of antimicrobial resistance.
Dr. Ashok Aspatwar
Dr. Wenping Gong
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tuberculosis
- Mycobacterium tuberculosis
- anti-tubercular drugs
- antimicrobial resistance
- host-directed therapy
- TB vaccines
- TB comorbidities
- translational therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
